Skip to main content

Becton Dickinson Greater Asia revenue

  • BDX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$218.03+1.08%Close 13 Nov 2026 · Market value $59.20B

Greater Asia revenue at Becton Dickinson came to $3.1B for the fiscal year to 30 Sep 2025, up 6.4% from a year earlier.

As Becton Dickinson reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 25 Nov 2025.

By fiscal year

$1.4BSep 2014$1.5BSep 2015$1.7BSep 2016$1.7BSep 2017$2.5BSep 2018$2.7BSep 2019$2.4BSep 2020$3.1BSep 2021$3.0BSep 2022$2.9BSep 2023$2.9BSep 2024$3.1BSep 2025
Becton Dickinson Greater Asia revenue, every reported period
Period endingGreater Asia revenueChange on a yearFiled
30 Sep 2025$3.1Bup 6.4%25 Nov 2025
30 Sep 2024$2.9Bdown 0.2%27 Nov 2024
30 Sep 2023$2.9Bdown 4.4%21 Nov 2023
30 Sep 2022$3.0Bdown 0.7%22 Nov 2022
30 Sep 2021$3.1Bup 28.7%24 Nov 2021
30 Sep 2020$2.4Bdown 12.5%25 Nov 2020
30 Sep 2019$2.7Bup 10.8%27 Nov 2019
30 Sep 2018$2.5Bup 41.1%21 Nov 2018
30 Sep 2017$1.7Bup 3.1%22 Nov 2017
30 Sep 2016$1.7Bup 9.5%23 Nov 2016
30 Sep 2015$1.5Bup 7.5%25 Nov 2015
30 Sep 2014$1.4Bup 6.9%26 Nov 2014
30 Sep 2013$1.3B—27 Nov 2013

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Becton Dickinson: Medical revenue · Medical Essentials revenue · Interventional revenue · Life Sciences (earlier basis) revenue · Connected Care revenue · BioPharma Systems revenue · EMEA revenue · United States revenue · International revenue · financial statements

Every KPI and segment of BDX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.